230 related articles for article (PubMed ID: 19952750)
1. Vaccine safety: current systems and recent findings.
Wharton M
Curr Opin Pediatr; 2010 Feb; 22(1):88-93. PubMed ID: 19952750
[TBL] [Abstract][Full Text] [Related]
2. Combination vaccines: postlicensure safety evaluation.
Chen RT; Pool V; Takahashi H; Weniger BG; Patel B
Clin Infect Dis; 2001 Dec; 33 Suppl 4():S327-33. PubMed ID: 11709768
[TBL] [Abstract][Full Text] [Related]
3. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
4. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
Nakayama T; Onoda K
Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
[TBL] [Abstract][Full Text] [Related]
5. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
[TBL] [Abstract][Full Text] [Related]
6. Safety monitoring in vaccine development and immunization.
Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
[TBL] [Abstract][Full Text] [Related]
7. Field evaluation of vaccine safety.
Tozzi AE
Vaccine; 2004 May; 22(15-16):2091-5. PubMed ID: 15121330
[TBL] [Abstract][Full Text] [Related]
8. [Postmarketing surveillance of secondary effects of vaccines].
Duclos P
Rev Epidemiol Sante Publique; 1994; 42(5):425-33. PubMed ID: 7973002
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies.
Chen RT
Vaccine; 2004 May; 22(15-16):2047-53. PubMed ID: 15121321
[TBL] [Abstract][Full Text] [Related]
10. Postlicensure epidemiology of childhood vaccination: the Danish experience.
Hviid A
Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
[TBL] [Abstract][Full Text] [Related]
11. Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.
Kanesa-thasan N; Shaw A; Stoddard JJ; Vernon TM
Pediatrics; 2011 May; 127 Suppl 1():S16-22. PubMed ID: 21502248
[TBL] [Abstract][Full Text] [Related]
12. [Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].
van der Maas NA; David S; Kemmeren JM; Vermeer-de Bondt PE
Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2732-7. PubMed ID: 18225797
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on the design and analysis of prelicensure trials: bridging the gap to postlicensure studies.
Black S
Clin Infect Dis; 2001 Dec; 33 Suppl 4():S323-6. PubMed ID: 11709767
[TBL] [Abstract][Full Text] [Related]
14. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
15. The Vaccine Safety Datalink project.
DeStefano F;
Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
[TBL] [Abstract][Full Text] [Related]
16. Adverse events following immunization: perception and evidence.
Bonhoeffer J; Heininger U
Curr Opin Infect Dis; 2007 Jun; 20(3):237-46. PubMed ID: 17471032
[TBL] [Abstract][Full Text] [Related]
17. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
[TBL] [Abstract][Full Text] [Related]
18. Methods of ensuring vaccine safety.
Ball R
Expert Rev Vaccines; 2002 Aug; 1(2):161-8. PubMed ID: 12901555
[TBL] [Abstract][Full Text] [Related]
19. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
[TBL] [Abstract][Full Text] [Related]
20. Monitoring and assessing vaccine safety: a European perspective.
Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
